0001628280-19-004762.txt : 20190425
0001628280-19-004762.hdr.sgml : 20190425
20190425201200
ACCESSION NUMBER: 0001628280-19-004762
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190423
FILED AS OF DATE: 20190425
DATE AS OF CHANGE: 20190425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Talasaz AmirAli
CENTRAL INDEX KEY: 0001753159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 19768989
MAIL ADDRESS:
STREET 1: 18 ISABELLA AVENUE
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
wf-form4_155623750501525.xml
FORM 4
X0306
4
2019-04-23
0
0001576280
Guardant Health, Inc.
GH
0001753159
Talasaz AmirAli
505 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
Chairman, President and COO
COMMON STOCK
2019-04-23
4
S
0
2697
66.06
D
3804080
I
Shares held by Talasaz and Eskandari 2017 Family Trust
COMMON STOCK
2019-04-23
4
S
0
30710
66.91
D
3773370
I
Shares held by Talasaz and Eskandari 2017 Family Trust
COMMON STOCK
2019-04-23
4
S
0
8318
67.65
D
3765052
I
Shares held by Talasaz and Eskandari 2017 Family Trust
COMMON STOCK
2019-04-23
4
S
0
1562
66.35
D
27443
I
Shares held by Samar Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-23
4
S
0
8044
67.03
D
19399
I
Shares held by Samar Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-23
4
S
0
1000
67.77
D
18399
I
Shares held by Samar Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-23
4
S
0
616
66.07
D
28389
I
Shares held by Sana Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-23
4
S
0
8180
66.92
D
20209
I
Shares held by Sana Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-23
4
S
0
1810
67.67
D
18399
I
Shares held by Sana Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-23
4
M
0
15202
4.18
A
19045
D
COMMON STOCK
2019-04-23
4
S
0
1410
66.17
D
17635
D
COMMON STOCK
2019-04-23
4
S
0
11957
66.92
D
5678
D
COMMON STOCK
2019-04-23
4
S
0
3240
67.63
D
2438
D
COMMON STOCK
2019-04-24
4
S
0
6778
65.28
D
3758274
I
Shares held by Talasaz and Eskandari 2017 Family Trust
COMMON STOCK
2019-04-24
4
S
0
10018
66.29
D
3748256
I
Shares held by Talasaz and Eskandari 2017 Family Trust
COMMON STOCK
2019-04-24
4
S
0
3136
66.92
D
3745120
I
Shares held by Talasaz and Eskandari 2017 Family Trust
COMMON STOCK
2019-04-24
4
S
0
1886
65.28
D
16513
I
Shares held by Samar Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-24
4
S
0
2780
66.43
D
13733
I
Shares held by Samar Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-24
4
S
0
400
66.93
D
13333
I
Shares held by Samar Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-24
4
S
0
2097
65.43
D
16302
I
Shares held by Sana Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-24
4
S
0
2869
66.45
D
13433
I
Shares held by Sana Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-24
4
S
0
100
67.22
D
13333
I
Shares held by Sana Talasaz 2018 Irrevocable Trust
COMMON STOCK
2019-04-24
4
M
0
7454
4.18
A
9892
D
COMMON STOCK
2019-04-24
4
S
0
3008
65.30
D
6884
D
COMMON STOCK
2019-04-24
4
S
0
4015
66.38
D
2869
D
COMMON STOCK
2019-04-24
4
S
0
909
66.99
D
1960
D
COMMON STOCK
737800
I
Shares held by Talasaz Investments, L.P.
STOCK OPTION (RIGHT TO BUY)
4.18
2019-04-23
4
M
0
15202
0
D
2027-07-13
COMMON STOCK
15202.0
1139454
D
STOCK OPTION (RIGHT TO BUY)
4.18
2019-04-24
4
M
0
7454
0
D
2027-07-13
COMMON STOCK
7454.0
1132000
D
These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.40 to $66.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.40 to $67.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.40 to $68.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.58 to $66.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.67 to $67.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.67 to $68.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.41 to $66.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.42 to $67.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.43 to $68.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares were acquired and then sold contemporaneously upon the cashless exercise of stock option at an exercise price of $4.18 per share.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.44 to $66.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.46 to $67.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.46 to $68.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.78 to $65.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.78 to $66.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.78 to $67.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.81 to $65.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.86 to $66.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.86 to $67.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.96 to $65.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.96 to $66.9, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.86 to $65.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.87 to $66.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.90 to $67.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.
/s/ Michael Wiley, as Attorney-in-Fact for AmirAli Talasaz
2019-04-25